LanzaTech UK Limited is a research-based technology incubator dedicated to fostering innovation through collaborative projects within the biotechnology sector, located in London’s central business district. Founded in October 2012 and currently active, LanzaTech operates as a limited liability company (Ltd) under registration number 08239599. The company employs a team of experienced researchers, engineers, and entrepreneurs committed to developing groundbreaking technologies with real-world impact. Lanzatech’s core mission centers on facilitating the creation of new ventures by providing intensive mentorship, access to resources, and strategic networking opportunities. They specialize in supporting startups across various stages – from initial concept validation through market testing - focusing on areas including drug discovery, diagnostics, and personalized medicine. The company's services encompass technology transfer, business development support, intellectual property protection, and funding assistance. LanzaTech UK actively recruits highly skilled individuals with a passion for biotechnology research and development. Lanzatech’s international presence is true, operating across Europe and North America. The company’s size estimate is significant, reflecting its commitment to impactful innovation. The primary focus of the company lies in biotechnology research and development, with a key industry concentration within SIC codes - 72110 – encompassing pharmaceutical, medical device, and related technology sectors.

LanzaTech UK Limited is a research-based technology incubator dedicated to fostering innovation through collaborative projects within the biotechnology sector, located in London’s central business district. Founded in October 2012 and currently active, LanzaTech operates as a limited liability company (Ltd) under registration number 08239599. The company employs a team of experienced researchers, engineers, and entrepreneurs committed to developing groundbreaking technologies with real-world impact. Lanzatech’s core mission centers on facilitating the creation of new ventures by providing intensive mentorship, access to resources, and strategic networking opportunities. They specialize in supporting startups across various stages – from initial concept validation through market testing - focusing on areas including drug discovery, diagnostics, and personalized medicine. The company's services encompass technology transfer, business development support, intellectual property protection, and funding assistance. LanzaTech UK actively recruits highly skilled individuals with a passion for biotechnology research and development. Lanzatech’s international presence is true, operating across Europe and North America. The company’s size estimate is significant, reflecting its commitment to impactful innovation. The primary focus of the company lies in biotechnology research and development, with a key industry concentration within SIC codes - 72110 – encompassing pharmaceutical, medical device, and related technology sectors.